Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.

Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):966-70. doi: 10.1002/ccd.21737.

PMID:
18942060
2.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators..

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

3.

Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.

Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.

Catheter Cardiovasc Interv. 2008 May 1;71(6):822-8. doi: 10.1002/ccd.21458.

PMID:
18324695
4.

Recurrent events after percutaneous closure of patent foramen ovale.

Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):541-6. doi: 10.1002/ccd.24511. Epub 2013 Jun 27.

PMID:
22707325
5.

Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.

Meier B.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):971-2. doi: 10.1002/ccd.21876. No abstract available.

PMID:
19021283
6.

Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.

Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL.

Cardiovasc Revasc Med. 2011 May-Jun;12(3):164-9. doi: 10.1016/j.carrev.2010.06.001. Epub 2010 Oct 20.

PMID:
21640934
7.

Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.

Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R.

Catheter Cardiovasc Interv. 2008 Feb 15;71(3):390-5. doi: 10.1002/ccd.21383.

PMID:
18288745
8.

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.

Catheter Cardiovasc Interv. 2017 Jan;89(1):124-133. doi: 10.1002/ccd.26518. Epub 2016 Mar 29.

PMID:
27027873
9.

Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.

Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.

Catheter Cardiovasc Interv. 2004 Aug;62(4):519-25.

PMID:
15274165
10.

Long-term experience and outcomes with transcatheter closure of patent foramen ovale.

Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW Jr, Palacios IF.

JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83. doi: 10.1016/j.jcin.2013.06.013.

11.

Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.

Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.

Am Heart J. 2008 Aug;156(2):356-60. doi: 10.1016/j.ahj.2008.03.006. Epub 2008 May 14.

PMID:
18657668
12.

Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years.

Fischer D, Gardiwal A, Haentjes J, Klein G, Meyer GP, Drexler H, Hausmann D, Schaefer A.

Clin Res Cardiol. 2012 Apr;101(4):297-303. doi: 10.1007/s00392-011-0392-2. Epub 2011 Dec 10.

PMID:
22159895
13.

Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.

Rudolph V, Augustin J, Hofmann T, Hamm CW, Meinertz T, Köster R, Baldus S, Franzen O.

EuroIntervention. 2014;9(12):1418-22. doi: 10.4244/EIJV9I12A239.

14.

Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.

Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.

Circulation. 2012 Feb 14;125(6):803-12. doi: 10.1161/CIRCULATIONAHA.111.030494. Epub 2012 Jan 11.

15.

Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.

Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.

Heart. 2008 Mar;94(3):336-41. Epub 2007 Jul 16.

PMID:
17639093
16.

Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.

Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1262-7. doi: 10.1002/ccd.25580. Epub 2015 Apr 2.

PMID:
24948394
17.

Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.

Rigatelli G, Dell'Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Rigatelli G, Chen JP.

JACC Cardiovasc Interv. 2010 Mar;3(3):282-7. doi: 10.1016/j.jcin.2009.11.019.

18.

Very long-term follow-up after percutaneous closure of patent foramen ovale.

Eeckhout E, Martin S, Delabays A, Michel P, Girod G.

EuroIntervention. 2015 Apr;10(12):1474-9. doi: 10.4244/EIJV10I12A257.

19.

Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.

Lehmann R, Fichtlscherer S, Baldauf H, Schächinger V, Auch-Schwelck W, Zeiher AM, Teupe C.

J Cardiol. 2014 Aug;64(2):113-6. doi: 10.1016/j.jjcc.2013.11.020. Epub 2014 Jan 27.

20.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators..

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390

Supplemental Content

Support Center